indiamed
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
facebook x icon x icon linkedin linkedin
new-product

Johnson & Johnson launches intraocular lens in India

IMT News Desk

The next-generation lens features a purely refractive design, delivering uninterrupted high-quality vision with high best-in-category contrast & low-light performance

Johnson & Johnson, a global leader in eye health, announced that its TECNIS PureSee purely refractive intraocular lens (IOL) for individuals with presbyopia is now available in India. The TECNIS PureSee IOL features a purely refractive design that delivers uninterrupted, high-quality vision with high best-in-category contrast and low-light performance, comparable to a monofocal IOL.

“Cataract surgery is the most common surgery performed globally, with 28 million procedures each year. But only 10-15 per cent of patients are getting advanced optical IOLs specifically designed for addressing issues of astigmatism and presbyopia, said Burzin Shahana, Country Manager, Surgical Vision India & South Asia, Johnson & Johnson MedTech. “We’re proud to launch the TECNIS PureSee IOL, giving surgeons and a growing number of patients in India the choice of a premium IOL that combines clarity of vision and reduced visual symptoms.”

While choosing any IOL, surgeons and patients have to consider many factors. For example, a lens that offers clear sight at all distances without spectacles may not be able to remove glares and halos. The purely refractive design of TECNIS PureSee lens addresses these issues and, therefore, improves the overall outcomes for both patients and surgeons.

With its purely refractive design, the TECNIS PureSee IOL ensures surgeons’ ease of use in providing high tolerance to refractive error.

Recommended

Alcon launches PRECISION1 contact lens

Herbalife India launches Sleep Enhance

AbbVie introduces Venetoclax in India, targeting blood cancer treatment gaps

Dräger introduces anaesthesia workstations Atlan A100

Sun Pharma introduces novel drug Fexuclue to treat erosive esophagitis

Cadila Pharma unveils migraine relief reformulated Vasograin EC

Alcon Introduces Personalised LASIK Treatment

Cadila Pharma launches Cadilose

Indiamedtoday

A premier media platform empowering healthcare professionals with critical business insights, news, and innovations to excel in a rapidly evolving industry.

EMAIL editorial@indiamedtoday.com

EMAIL sales@indiamedtoday.com

quick links

news health it interview opinion strategy magazine privacy policy terms and conditions

subscribe to our newsletter

Stay updated with the latest breakthroughs in Indian healthcare, medical research, and wellness insights.

    follow us

    facebook x icon x icon linkedin linkedin
    Copyright © 2025 INDIAMED TODAY Marketed By Screetract Solutions